Lipid lowering therapy in patients with HIV infection.
McBride
M
M
Chin
M T
MT
Lee
S M
SM
Kelly
B
B
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000097:blood / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000139:chemically induced*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010192:Pancreatic Pseudocyst / Q000097:blood / Q000139:chemically induced*; D010195:Pancreatitis / Q000097:blood / Q000139:chemically induced*; D012307:Risk Factors; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use; D019258:Saquinavir / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D008055:Lipids; D019258:Saquinavir; D019438:Ritonavir